GENE WRITING
Dead / Abandoned — Abandoned — failure to respond (as of 27 Mar 2023)
What this means for you
This application is over — abandoned 13 Mar 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90071417
- Mark type
- Stylized text
- Filed
- 24 Jul 2020
- Abandoned
- 13 Mar 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA
Owner
- Tessera Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 28 Mar 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 27 Mar 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 27 Mar 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 02 Dec 2022 — ASSIGNED TO EXAMINER
- 12 Sept 2022 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 12 Sept 2022 — SUBSEQUENT FINAL EMAILED
- 12 Sept 2022 — SUBSEQUENT FINAL REFUSAL WRITTEN
- 12 Aug 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Aug 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Aug 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2022 — NON-FINAL ACTION E-MAILED
- 11 Feb 2022 — NON-FINAL ACTION WRITTEN
- 07 Dec 2021 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 06 Dec 2021 — USE AMENDMENT ACCEPTED